SASY - Trade Savi - 360-degree view on crypto market

ATOS BICP CL CLARI DX EUR/GBP EUR/USD FCHI GC HRMS LCO MT OREP SASY SBF120 TEPRF VIV VLLP

France stocks higher at close of trade; CAC 40 up 0.12%

France stocks rose with gains in healthcare, consumer goods, and tech sectors. Sanofi led CAC 40 gains, while several firms reached all-time lows.

investing.com • 17/12/2024 - 17:05 PM

SASY SNY TEVA

Teva stock soars on positive Phase 2b study results

Teva shares rose 17% after positive Phase 2b results for duvakitug, a drug for inflammatory bowel disease, showing promise in treating ulcerative colitis and Crohn’s disease.

investing.com • 17/12/2024 - 13:37 PM

REGN SASY

Sanofi shares rise as Q3 results beat forecasts on vaccines and Beyfortus sales

Sanofi's shares rose due to strong Q3 results, driven by vaccine sales and Beyfortus revenue, exceeding expectations and boosting outlook for 2024 and beyond.

investing.com • 25/10/2024 - 07:22 AM

SASY SNY

Sanofi and CD&R enter exclusive talks for Opella sale

Sanofi is negotiating to sell a controlling stake in its consumer healthcare unit, Opella, to CD&R, aiming to focus on innovative medicines and streamline its business.

investing.com • 21/10/2024 - 07:52 AM

CL DX EUR/GBP EUR/USD FCHI GC LCO SASY SBF120

France stocks mixed at close of trade; CAC 40 up 0.20%

French stocks ended mixed with the CAC 40 up 0.20% while the SBF 120 fell 0.07%, influenced by varying performances across sectors and notable individual stocks.

investing.com • 02/09/2024 - 16:05 PM

France stocks higher at close of trade; CAC 40 up 0.12%

Teva stock soars on positive Phase 2b study results

Sanofi shares rise as Q3 results beat forecasts on vaccines and Beyfortus sales

Sanofi and CD&R enter exclusive talks for Opella sale

France stocks mixed at close of trade; CAC 40 up 0.20%

Greed and Fear Index

Currency